Cannabis sector developments and NYSE Composite discussions intensified after federal CBD enforcement changes, highlighting ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

The Global CBD Isolate Market is witnessing substantial expansion as manufacturers increasingly adopt standardized ...

Ananda Pharma Limited is a UK pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions.

UK-based Ananda Pharma has announced successful completion of its Phase 1 pharmacokinetic study of its MRX1 cannabidiol oral solution to treat chronic pain conditions, with all study objectives met.

Cannabidiol (CBD) is a naturally occurring compound found in cannabis, thought to have beneficial effects on things like ...

Giving mice a chemically induced epileptic condition and then adding nicotine does not prove that nicotine causes or worsens ...

Visitors to Booth 710 will have the opportunity to explore Hometown Hero's growing lineup of hemp-derived drink offerings, ...

Cannabidiol (CBD) has been shown to reduce brain inflammation in a mouse model of Alzheimer's disease. | Cannabis Sciences ...

Clinical-stage company targets 2028–2029 IBS patent cliff with mechanism-distinct cannabinoid approach MIDDLETOWN, RI, ...

All study objectives met MRX1 well tolerated, Phase 2 dosing on track to start H2 2026 Data reinforces case for therapeutic doses of MRX1 Oral SolutionFurther confidence on regulatory and clinical ...

Discover the challenges CBD businesses face with credit card processing and learn how to navigate the complexities of payment ...